Conservative treatments: Medical/Drug therapies

Venous and Lymphatic Diseases

Volumn , Issue , 2006, Pages 257-275

  Kakkos, Stavros K ^a   Perrin, Michel ^b   Cutting, Keith F ^a   Geroulakos, George ^a,c  

^a EALING HOSPITAL   (United Kingdom)

^b UNIVERSITÉ DE LYON   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971564225     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (135)

1. Laufmann H, Clio Chirurgica. The Veins. Austin, TX: Silvergirl, Inc., 1986.
2. Evers EJ, Wuppermann T. Effect of different compression therapies on the reflux in deep veins with a post-thrombotic syndrome. Vasa 1999; 28:19-23.
3. Christopoulos DG, Nicolaides AN, Szendro G, Irvine AT, Bull ML, Eastcott HHG. Air-plethysmography and the effect of elastic compression on venous hemodynamics of the leg. J Vasc Surg 1987; 5:148-159.
4. Partsch H, Menzinger G, Mostbeck A. Inelastic leg compression is more effective to reduce deep venous refluxes than elastic bandages. Dermatol Surg 1999; 25:695-700.
5. Ibegbuna V, Delis K, Nicolaides AN. Effect of lightweight compression stockings on venous haemodynamics. Int Angiol 1997; 16:185-188.
6. Spence RK, Cahall E. Inelastic versus elastic leg compression in chronic venous insufficiency: a comparison of limb size and venous hemodynamics. J Vasc Surg 1996; 24:783-787.
7. Ibegbuna V, Delis KT, Nicolaides AN, Aina O. Effect of elastic compression stockings on venous hemodynamics during walking. J Vasc Surg 2003; 37:420-125.
8. Samson RH, Scher LH, Veith FJ, Gupta SK, Ascer E. Photoplethysmographic evaluation of external compressive therapy for chronic venous ulceration. J Cardiovasc Surg (Torino) 1986; 27:24-26.
9. Horner J, Fernandes J, Fernandes E, Nicolaides AN. Value of graduated compression stockings in deep venous insufficiency. Br Med J 1980; 280:820-821.
10. O'Donnell TF, Jr., Rosenthal DA, Callow AD, Ledig BL. Effect of elastic compression on venous hemodynamics in postphlebitic limbs. JAMA 1979; 242:2766-2768.
11. Partsch H, Menzinger G, Borst-Krafek B, Groiss E. Does thigh compression improve venous hemodynamics in chronic venous insufficiency? J Vasc Surg 2002; 36:948-952.
12. Buhs CL, Bendick PJ, Glover JL. The effect of graded compression elastic stockings on the lower leg venous system during daily activity. J Vasc Surg 1999; 30:830-834.
13. Hirai M, Iwata H, Hayakawa N. Effect of elastic compression stockings in patients with varicose veins and healthy controls measured by strain gauge plethysmography. Skin Res Technol 2002; 8:236-239.
14. Nehler MR, Moneta GL, Woodard DM, et al. Perimalleolar subcutaneous tissue pressure effects of elastic compression stockings. Vasc Surg 1993; 18:783-788.
15. Christopoulos DC, Nicolaides AN, Belcaro G, Kalodiki E. Venous hypertensive microangiopathy in relation to clinical severity and effect of elastic compression. J Dermatol Surg Oncol 1991; 17:809-813.
16. Leon M, Volteas N, Labropoulos N, et al. The effect of elastic stockings on the elasticity of varicose veins. Int Angiol 1993; 12:173-177.
17. Labropoulos N, Leon M, Volteas N, Nicolaides AN. Acute and long-term effect of elastic stockings in patients with varicose veins. Int Angiol 1994; 13:119-123.
18. Back TL, Padberg FT, Jr., Araki CT, Thompson PN, Hobson RWII. Limited range of motion is a significant factor in venous ulceration. J Vasc Surg 1995; 22:519-523.
19. Nelson EA, Iglesias CP, Cullum N, Torgerson DJ. VenUS I collaborators. Randomized clinical trial of four-layer and short-stretch compression bandages for venous leg ulcers (VenUS I). Br J Surg 2004; 91:1292-1299.
20. Blair SD, Wright DD, Backhouse CM, Riddle E, McCollum CN. Sustained compression and healing of chronic venous ulcers. BMJ 1988; 297:1159-1161.
21. Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2001;CD000265.
22. Pierson S, Pierson D, Swallow R, Johnson G, Jr. Efficacy of graded elastic compression in the lower leg. JAMA 1983; 249:242-243.
23. Buchtemann AS, Steins A, Volkert B, Hahn M, Klyscz T, Junger M. The effect of compression therapy on venous haemodynamics in pregnant women. Br J Obstet Gynaecol 1999; 106:563-569.
24. Vayssairat M, Ziani E, Houot B. Efficacité versus placebo de la contention classe 1 dans l'insuffisance veineuse chronique des membres inferieurs. J Mal Vasc 2000; 25:256-262.
25. Motykie GD, Caprini JA, Arcelus JI, Reyna JJ, Overom E, Mokhtee D. Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg 1999; 25:116-120.
26. Johnson G, Jr., Kupper C, Farrar DJ, Swallow RT. Graded compression stockings: custom vs noncustom. Arch Surg 1982; 117:69-72.
27. Charles H. Does leg ulcer treatment improve patients' quality of life? J Wound Care 2004; 13:209-213.
28. Loftus S. A longitudinal, quality of life study comparing four layer bandaging and superficial venous surgery for the treatment of venous leg ulcers. J Tissue Viability 2001; 11:14-19.
29. Barwell JR, Davies CE, Deacon J, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomized controlled trial. Lancet 2004; 363:1854-1859.
30. Meyer FJ, McGuinness CL, Lagattolla NR, Eastham D, Burnand KG. Randomized clinical trial of three-layer paste and four-layer bandages for venous leg ulcers. Br J Surg 2003; 90:934-940.
31. Ukat A, Konig M, Vanscheidt W, Munter KC. Short-stretch versus multilayer compression for venous leg ulcers: a comparison of healing rates. J Wound Care 2003; 12:139-143.
32. O'Brien JF, Grace PA, Perry IJ, Hannigan A, Clarke Moloney M, Burke PE. Randomized clinical trial and economic analysis of four-layer compression bandaging for venous ulcers. Br J Surg 2003; 90:794-798.
33. Samson RH, Showalter DP. Stockings and the prevention of recurrent venous ulcers. Dermatol Surg 1996; 22:373-376.
34. Zamboni P, Cisno C, Marchetti F, et al. Minimally invasive surgical management of primary venous ulcers vs compression treatment: a randomized clinical trial. Eur J Vasc Endovasc Surg 2003; 25:313-318.
35. DePalma RG, Kowallek DL. Venous ulceration: a cross-over study from nonoperative to operative treatment. J Vasc Surg 1996; 24:788-792.
36. Scurr JH, Coleridge-Smith P, Cutting P. Varicose veins: optimum compression following sclerotherapy. Ann R Coll Surg Engl 1985; 67:109-111.
37. Shouler PJ, Runchman PC. Varicose veins: optimum compression after surgery and sclerotherapy. Ann R Coll Surg Engl 1989; 71:402-104.
38. Travers JP, Rhodes JE, Hardy JG, Makin GS. Postoperative limb compression in reduction of haemorrhage after varicose vein surgery. Ann R Coll Surg Engl 1993; 75:119-122.
39. Kiev J, Noyes LD, Rice JC, Kerstein MD. Patient compliance with fitted compression hosiery monitored by photoplethysmography. Arch Phys Med Rehabil 1990; 71:376-379.
40. Mayberry JC, Moneta GL, Taylor LM, Jr., Porter JM. Fifteen-year results of ambulatory compression therapy for chronic venous ulcers. Surgery 1991; 109:575-581.
41. Korn P, Patel ST, Heller JA, et al. Why insurers should reimburse for compression stockings in patients with chronic venous stasis. J Vasc Surg 2002; 35:950-957.
42. Moffatt CJ, McCullagh L, O'Connor T, et al. Randomized trial of four-layer and two-layer bandage systems in the management of chronic venous ulceration. Wound Repair Regen 2003; 11:166-171.
43. Iglesias CP, Nelson EA, Cullum N, Torgerson DJ. On behalf of the VenUS I collaborators. Economic analysis of VenUS I, a randomized trial of two bandages for treating venous leg ulcers. Br J Surg 2004; 91:1300-1306.
44. Scriven JM, Taylor LE, Wood AJ, Bell PR, Naylor AR, London NJ. A prospective randomised trial of four-layer versus short stretch compression bandages for the treatment of venous leg ulcers. Ann R Coll Surg Engl 1998; 80:215-220.
45. Merrett ND, Hanel KC. Ischaemic complications of graduated compression stockings in the treatment of deep venous thrombosis. Postgrad Med J 1993; 69:232-234.
46. Chan CLH, Meyer FJ, Hay RJ, Burnand KG. Toe ulceration associated with compression bandaging: observational study. BMJ 2001; 323:1099.
47. Neumann HA. Compression therapy with medical elastic stockings for venous diseases. Dermatol Surg 1998; 24:765-770.
48. Veraart JC, Daamen E, de Vet HC, Neumann HA. Elastic compression stockings: durability of pressure in daily practice. Vasa 1997; 26:282-286.
49. Coleridge-Smith P, Sarin S, Hasty J, Scurr JH. Sequential gradient pneumatic compression enhances venous ulcer healing: a randomized trial. Surgery 1990; 108:871-875.
50. Mani R, Vowden K, Nelson EA. Intermittent pneumatic compression for treating venous leg ulcers. Cochrane Database Syst Rev 2001;CD001899.
51. Rowland J. Intermittent pneumatic compression versus compression bandages in the treatment of venous leg ulcers. Aust NZ J Surg 2000; 70:110-113.
52. Arcelus JI, Caprini JA, Sehgal LR, Reyna JJ. Home use of impulse compression of the foot and compression stockings in the treatment of chronic venous insufficiency. J Vasc Surg 2001; 34:805-811.
53. Berliner E, Ozbilgin B, Zarin DA. A systematic review of pneumatic compression for treatment of chronic venous insufficiency and venous ulcers. J Vasc Surg 2003; 37:539-544.
54. Padberg FT, Jr., Johnston MV, Sisto SA. Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomized trial. J Vasc Surg 2004; 39:79-87.
55. Kan YM, Delis KT. Hemodynamic effects of supervised calf muscle exercise in patients with venous leg ulceration: a prospective controlled study. Arch Surg 2001; 136:1364-1369.
56. Valencia IC, Falabella AF, Eaglstein WH. Skin grafting. Dermatol Clin 2000; 18:521-532.
57. Cuono CB, Langdon R, Birchall N, Barttelbort S, McGuire J. Composite autologous-allogeneic skin replacement: Development and clinical application. Plast Reconstr Surg 1987; 80:626-637.
58. Desai MH, Mlakar JM, McCauley RL, et al. Lack of long-term durability of cultured keratinocyte burn-wound coverage: a case report. Burn Care Rehabil 1991; 12:540-545.
59. Gallico GG, III. Biologic skin substitutes. Clin Plast Surg 1990; 17:519-526.
60. Eisenbud D, Huang NF, Luke S, Silberklang M. Skin Substitutes and Wound Healing: Current Status and Challenges. Wounds 2004; 16:2-17.
61. Sibbald RG, Torrance GW, Walker V, et al. Cost-effectiveness of Apligraf in the treatment of venous leg ulcers. Ost Wound Manage 2001; 47:36-46.
62. Harding K, Cutting K, Price P. The cost-effectiveness of wound management protocols of care. Br J Nurs 2000; 9:S6,S8,S10.
63. Kirsner RS, Fastenau J, Falabella A, et al. Clinical and economic outcomes with graftskin for hard-to-heal venous leg ulcers: A single-center experience. Dermatol Surg 2002; 28:81-82.
64. Nunez-Gutierrez H, Castro-Munozledo F, Kuri-Harcuch W. Combined use of allograft and autograft epidermal cultures in therapy of burns. Plast Reconstr Surg 1996; 98:929-939.
65. Redekop WK, McDonnell J, Verboom P, et al. The cost effectiveness of Apligraf® treatment of diabetic foot ulcers. Pharmacoeconomics 2003; 21:1171-1183.
66. Lindgren C, Marcusson JA, Toftgard R. Treatment of venous leg ulcers with cryopreserved cultured allogeneic keratinocytes: a prospective open controlled study. Br J Dermatol 1998; 139:271-275.
67. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF ) accelerates complete closure of hard to heal venous leg ulcers. Wound Rep Reg 1999; 7:201-207.
68. Hjerppe A, Hjerppe M, Autio V, Raudasoja R, Vaalasti A. Treatment of chronic leg ulcers with a human fibroblast-derived dermal substitute: a case series of 114 patients wounds. Wounds 2004; 16:97-104.
69. Ramelet AA, Kern P, Perrin M, eds. Varicose veins and telangiectasias. Paris: Masson, 2003. Chapter 1 (definitions), pp. 7-16.
70. Porter JM, Moneta GL. International Consensus Committee on chronic venous disease. Reporting standards in venous disease: an update. J Vasc Surg 1995; 21:635-645.
71. Garde C, Perrin M, Chleir F, Henriet JP, et al. First meeting of review and consensus on venoactive agents on the symptoms of chronic venous disease (in French). Phlebologie 2003; 56:103-109.
72. Ramelet AA, Kern P, Perrin M, eds. Varicose veins and telangiectasias. Paris: Masson, 2003. Chapter 13 (Drug therapy) pp. 166-168.
73. Boisseau MR. Pharmacologie des medicaments veinotoniques: donnees actuelles sur leur mode d'action et les cibles therapeutiques.(in French). Angeiologie 2000; 52:71-77.
74. Clarke GH, Vasdekis SN, Hobbs JT, Nicolaides AN. Venous wall function in the pathogenesis of varicose veins. Surgery 1992; 111:402-408.
75. Boisseau M, Freyburger G, Busquet M, et al. Hemorheological disturbances in venous insufficiency after induced stasis. Clin Hemorheol 1989; 9:161-163.
76. Le Devehat C, Boisseau MR, Vimeux M, et al. Hemorheological factors in the pathophysiology of venous disease. Clin Hemorheol 1989; 9:861-870.
77. Taccoen A, Belcaro G, Lebard C, Zuccarelli F. Etiologies et mecanismes des varices: realites et perspectives. STV 1997; 9:354-363.
78. Boisseau MR, Taccoen A, Garreau C, et al. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency. J Cardiovasc Surg 1995; 36:369-374.
79. Saharay M, Shields DA, Georgiannos SN, et al. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 1998; 15:342-349.
80. Michiels C, Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Janssens D, Remacle J. Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia. Int Angiol 1997; 16:135-141.
81. Michiels C, De Leener F, Arnould T, Dieu M, Remacle J. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF. Exp Cell Res 1994; 213:43-54.
82. Badier-Commander C, Couvelard A, Henin D, Verbeuren T, Michel JB, Jacob MP. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 2001; 193:398-407.
83. Takase S, Pascarella L, Bergan J, Schmid-Schonbein GW. Hypertension-induced valve remodeling. J Vasc Surg 2004; 39:1329-1334.
84. Janssens D, Delaive E, Houbion A, Eliaers F, Remacle J, Michiels C. Effect of venotropic drugs on the respiratory activity of isolated mitochondria and in endothelial cells. Br J Pharmacol 2000; 130:1513-1524.
85. Michiels C, Bouaziz N, Remacle J. Role of the endothelium and blood stasis in the appearance of varicose veins. Int Angiol 2002; 21:1-8.
86. Takase S, Pascarella L, Lerond L, Bergan J, Schmid-Schönbein GW. Venous Hypertension. Inflammation and Valve Remodeling. Eur J Vasc Endovasc Surg 2004; 28:484-493.
87. Shoab SS, Porter JB, Coleridge-Smith PD. Effect of oral micronised flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot study. J Vasc Surg 2000; 31:456-461.
88. Agence Nationale d'Accreditation et d'Evaluation de la Sante (in French). Evaluation et suivi de la douleur chronique chez l'adulte en medecine ambulatoire (in French). www.anaes.fr.
89. Launois R, Reboul-Marty J, Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res 1996; 5:539-550.
90. Lamping DL, Abenhaim L, Kurz X, et al. Measuring quality of life and symptoms in chronic venous disorders of the leg: development and psychometric evaluation of the VEINES-Qol/SYM questionnaire. Qual Life Res 1998; 7:621-622.
91. Klyscz T, Junder M, Schanz S, Janz M, Rassner G, Kohnen R. Quality of Life in chronic venous insufficiency (CVI). Results of a study with the newly developed Tubingen questionnaire for measuring quality of life with CVI. Hautartz 1998; 49:372-381.
92. Hachen HJ, Lorenz P. Double-blind clinical and plethysmographic study of calcium dobesilate in patients with peripheral microvascular disorders. Angiology 1982; 33:480-487.
93. Labs KH, Degischer S, Gamba G, Jaeger KA. Effectiveness and safety of calcium dobesilate in treating chronic venous insufficiency: randomized, double-blind, placebo-controlled trial. Phlebology 2004; 19:123-130.
94. Casley-Smith JR. A double blind trial of calcium dobesilate in chronic venous insufficiency. Angiology 1988; 39:853-857.
95. Pecchi S, De Franco V, Damiani P, et al. Calcium dobesilate in the treatment of primary venous insufficiency of the lower limbs. A controlled clinical study. Clin Ter 1990; 32:409-417.
96. Widmer L, Biland L, Barras JP. Doxium 500 in chronic venous insufficiency: a double-blind placebo-controlled multicentre study. Int Angiol 1990; 9:105-110.
97. Le Devehat C, Lemoine A, Roux E, et al. Aspects clinique et hemodynamique de Cyclo 3 dans l'insuffisance veineuse. (in French). Angeiologie 1984; 36:119-122.
98. Sentou Y, Bernard-Fernier MF, Demarez JP, et al. Symptomatologie et plethysmographie: parallelisme des resultats obtenus lors d'un traitment par Cyclo 3 de patients porteuses d'une insuffisance veineuse chronique (etude en double insu contre placebo). Gaz Med 1985; 92:73-77.
99. Petruzzellis V, Troccoli T, Candiani C, et al. Oxerutins (Venoruton): efficacy in chronic venous insufficiency-a double-blind, randomized, controlled study. Angiology 2002; 53:257-263.
100. Balmer A, Limoni C. Adouble blind placebo controlled clinical trial of Venoruton on the symptoms and signs of chronic venous insufficiency. The importance of patient selection. VASA 1980; 9:1-7.
101. MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability. Gerontology 1994; 40:45-52.
102. Chassignolle J-F, Amiel M, Lanfranchi G, et al. Activité thérapeutique de Daflon 500 mg dans l'insuffisance veineuse fonctionnelle [in French]. J Int Med 1987; 99:32-37.
103. Gilly R, Pillion G, Frileux C. Evaluation of a new venoactive micronized flavonoid fraction (S 5682) in symptomatic disturbances of the veinolymphatic circulation of the lower limb: a double-blind, placebo-controlled study. Phlebology 1994; 9:67-70.
104. Cospite M, Dominici A. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form. Int Angiol 1989; 8:61-65.
105. Tsouderos Y. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg Int Angiol 1989; 8:53-59.
106. Ciapponi A, Laffaire E, Roque M. Calcium dobesilate for chronic venous insufficiency: a systermatic review. Angiology 2004; 55:147-154.
107. Arceo A, Berber A, Trevino C. Clinical evaluation of the efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency of the lower limbs. Angiology 2002; 53:539-544.
108. Poynard T, Valterio C. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency. VASA 1994; 23:244-250.
109. Wadworth AV, Faulds D. Hydroxyethylrutosides: a review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders. Drugs 1992; 44:1013-1032.
110. Boyle P, Diehm C, Robertson C. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. Int Angiol 2003; 22:250-262.
111. Siebert U, Brach M, Sroczynski G, et al. Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency. A meta-analysis of randomized controlled trials and large observational studies. Int Angiol 2002; 21:305-315.
112. Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. Arch Dermatol 1998; 134:1356-1360.
113. Geroulakos G, Nicolaides AN. Controlled studies of Daflon 500 mg in chronic venous insufficiency. Angiology 1994; 45:549-553.
114. Lyseng-Williamson KA, Perry CM. Micronised Purified Flavonoid Fraction. A review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs 2003; 63:71-100.
115. Boada JN. Therapeutic effect of venotonics in chronic venous insufficiency. Clin Drug Invest 1999; 18:413-432.
116. Jantet G, the RELIEF Study Group. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of life improvEment with micronized Flavonoids. Angiology 2002; 53:245-256.
117. Berard A, Kurz X, Zuccarelli F, et al. Reliability study of Leg-O-Meter, an improved tape measure device in patients with chronic venous insufficiency of the leg. Angiology 1998; 49:169-173.
118. Brijker F, Heijdra YF, Van den Elshout FJJ, et al. Volumetric measurements of peripheral oedema in clinical conditions. Clin Physio 2000; 20:56-61.
119. Vayssairat M, Maurel A, Gouny, et al. La volumetrie: une methode precise de quantification en phlebologie (in French). J Mal Vasc 1994; 19:108-110.
120. Garde C, Nicolaides A, Guex JJ, Grondin L, et al. Consensus meeting on the action of phlebotropic drugs on chronic venous disease-related edema (in French). Phlebologie 2004; 57:7-13.
121. Stanton AWB, Northfield JW, Holroyd B, et al. Validation of an optoelectronic limb volumeter (Perometer®). Lymphology 1997; 30:77-97.
122. Perrin M, Guex JJ. Edema and leg volume: methods of assessment. Angiology 2000; 51:9-12.
123. Vayssairat M. and the French Venous Naphtazone Trial Group. Placebo-controlled trial of naphtazone in women with primary uncomplicated symptomatic varicose veins. Phlebology 1997; 12:17-20.
124. Diehm C, Trampish HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut extract therapy in patients with chronic venous insufficiency. Lancet 1996; 347:292-294.
125. Blume J, Langenbahn H, de Champvallins M. Quantification of edema using the volometer technique; therapeutic application of Daflon 500 mg in chronic venous insufficiency. Phlebology 1992; 7:S37-S40.
126. Cesarone MR, Belcaro G, Brandolini R, et al. The LONFLIT4-Venoruton Study: a randomized trial-prophylaxis of flight-edema in venous patients. Angiology 2003; 54:137-142.
127. Cesarone MR, Belcaro G, Geroulakos G, et al. Flight microangiopathy on long-haul flights: prevention of edema and microcirculation alterations with Venoruton. Clin Appl Thromb Hemost 2003; 9:109-114.
128. Guilhou J-J, Dereure O, Marzin L, et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997; 48:77-85.
129. Glinski W, Chodynicka B, Roszkiewicz J, et al. The beneficial augmentative effect of micronised purified flavonoid fraction (MPFF) on the healing of leg ulcers: an open, multicentre, controlled, randomised study. Phlebology 1999; 14:151-157.
130. Roztocil K, Stvrtinova V, Strejcek J. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency. Int Angiol 2003; 22:24-31.
131. Ramelet AA. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology 2001; 52:S49-S56.
132. Ramelet AA, Coleridge-Smith PD, Gloviczki P. A meta-analysis of venous leg ulcer healing in prospective randomised studies using Micronized Purified Flavonoid Fraction. J Mal Vasc 2004; 29:1S43.
133. OttillingerB, GreeskeK. Rational therapy of chronic venous insufficiency-chances and limits of the therapeutic use of horse-chestnut seeds extract. BMC Cardiovasc Disord 2001; 1:5.
134. Wright DD, Franks PJ, Blair SD, Backhouse CM, Moffatt C, McCollum CN. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial. Br J Surg 1991; 78:1269-1270.
135. Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg ulcers: a systematic review. Lancet 2002; 359:1550.